This decision aid is designed to help adults with long COVID (also known as post COVID-19 condition) to decide whether to try low-dose naltrexone (LDN) for management of symptoms. It may also be helpful for caregivers and healthcare professionals involved in shared decision-making.
Options
- Start treatment with LDN at a dose ranging between 1.5-6.0 mg.
- Do not start treatment with LDN.
- Not sure.
Who is this tool for?
You can benefit from this decision aid if you:
- Are an adult with long COVID.
- Are a caregiver or family member of an adult with long COVID.
How can you use this tool?
- You may review the information to make an informed decision about LDN treatment.
- You may review this information to prepare for a discussion about LDN treatment for long COVID with a healthcare professional.
- You may also exit the tool now and leave the decision to your healthcare professional.
Remember: you may quit this decision aid at any time. When you continue with this decision aid you may skip any step by clicking "next" in the bottom right-hand corner of the screen. You may also go back to the previous step by clicking "back".
How can this tool help you?
This interactive decision aid will help you:
- Understand the benefits and harms of receiving LDN for long COVID.
- Think about how important the different benefits and harms are for you.
- Make a final decision whether or not to start LDN.